Table 2.
Clinical and laboratory findings of the PCR-positive patients.
| Patient no. | Age, year | Gestational week | COVID-19 Status |
COVİD-19 Symptom |
Lymphocyte (103/mm3) | CRP (mg/dL) | IL-6 (pg/mL) | COVID-19 Treatment |
rt-PCR result of the abortion material |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 32 | 9 | Mild | Cough, fatigue | 1080 | 4,6 | 16,8 | Hydroxychloroquine | Negative |
| 2 | 33 | 16 | Asymptomatic | None | 1590 | 13,6 | 7,59 | None | Negative |
| 3 | 16 | 18 | Asymptomatic | None | 520 | 56 | – | None | Negative |
| 4 | 35 | 12 | Asymptomatic | None | 1250 | 9,3 | 7,79 | None | Negative |
| 5 | 34 | 8 | Asymptomatic | None | 1790 | 14,1 | 10,8 | None | Invalid |
| 6 | 38 | 10 | Mild | Diarrhea, fatigue | 1970 | 3,9 | 6,03 | Favipiravir | Negative |
| 7 | 33 | 6 | Asymptomatic | None | 790 | 103,7 | 126 | None | Negative |
| 8 | 33 | 9 | Asymptomatic | None | 1290 | 14,1 | – | None | Negative |
| 9 | 31 | 5 | Asymptomatic | None | 1700 | 11,7 | 5,8 | None | Negative |
| 10 | 27 | 19 | Critical | Respiratory and multi-organ failure | 820 | 156 | 23 | Lopinavir-ritonavir, corticosteroid, IL-1 receptor antagonist | Invalid |
| 11 | 35 | 17 | Asymptomatic | None | 1630 | 140,8 | – | None | Negative |
| 12 | 31 | 14 | Asymptomatic | None | 1180 | – | – | None | Invalid |
| 13 | 43 | 7 | Mild | Sore throat | 1400 | 32,4 | 10,2 | Hydroxychloroquine | Negative |
| 14 | 30 | 9 | Asymptomatic | None | 1030 | 33,8 | – | None | Negative |
| 15 | 28 | 7 | Asymptomatic | None | 1920 | 10,1 | – | None | Negative |
| 16 | 29 | 7 | Asymptomatic | None | 1520 | 5,7 | – | None | Negative |
| 17 | 37 | 10 | Mild | Cough, fever | 1940 | 118,6 | 6,51 | Hydroxychloroquine | Negative |
| 18 | 34 | 10 | Asymptomatic | None | 1420 | 13,8 | – | None | Negative |
| 19 | 28 | 8 | Asymptomatic | None | 2800 | 1,1 | 3,37 | None | Negative |
| 20 | 24 | 8 | Asymptomatic | None | 2130 | 3,8 | 7,02 | None | Negative |
| 21 | 28 | 9 | Asymptomatic | None | 1430 | – | – | None | Negative |
| 22 | 21 | 8 | Asymptomatic | None | 1240 | 1,6 | – | None | Negative |
| 23 | 31 | 7 | Asymptomatic | None | 1780 | 0,9 | – | None | Negative |
| 24 | 23 | 18 | Asymptomatic | None | 1110 | 24,2 | – | None | Negative |